Metabolon is pleased to participate in the 18th Annual Biomarkers Congress in Manchester, United Kingdom. The congress, also known as Biomarkers 2023, is designed to provide insights into trends and tools impacting biomarker research.
Search
Recent Posts
- Metabolon Collaborates with The Michael J. Fox Foundation to Advance Multiomic Analyses for Parkinson’s Research
- Metabolon’s Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity
- ADPD 2026
- Metabolon Names Andrew Messick Chief Financial Officer
- Metabolon Appoints Celia Reyes as Vice President of Human Resources
Recent Comments